肝癌微波治疗术对患者肾功能影响因素的分析

doi:10.11904/j.issn.1002-3070.2015.03.005

摘要/Abstract

摘要：

目的探讨肝癌微波治疗术期出现肾功能不全的影响因素。方法回顾性分析在2012年6月—2014年12月期间,哈尔滨医科大学附属肿瘤医院肝胆外科治疗的80例行肝癌微波治疗术患者的临床资料;根据围术期有无出现肾功能不全,将患者分为肾功能不全组(n=44)与肾功能正常组(n=36);对比分析两组患者术前ALT、TBIL、BUN、术中低血压、术中尿量、年龄、微波消融时间、肿瘤与肝大血管距离、微波消融范围、性别等危险因素的差异。结果肾功能不全组与肾功能正常组患者之间的术中尿量无统计学差异(P＞0.05);而肾功能不全组与肾功能正常组患者之间的术前ALT、TBIL、BUN、术中低血压、年龄、微波消融时间、肿瘤与肝大血管距离、微波消融范围和性别具有统计学差异(P＜0.05)。BUN与术前ALT、术前TBIL、术前BUN、术中低血压、年龄、肿瘤与肝大血管距离、微波消融时间、微波消融范围、性别影响因素均呈正相关(r=0.63、0.60、0.58、0.49、0.45、0.40、0.35、0.46、0.52,P＜0.05)。BUN的影响因素强弱依次为肿瘤与肝大血管距离、微波消融范围、术中低血压、术前ALT、性别、术前TBIL、微波消融时间、年龄和术前BUN(标准化回归系数分别为-0.52、0.42、0.37、0.31、0.29、0.25、0.20、0.18和0.16,P＜0.05)。结论肝癌微波治疗术患者出现肾功能不全的危险因素呈多方面,与术前ALT、术前TBIL、术前BUN、术中低血压、年龄、肿瘤与肝大血管距离、微波消融时间、微波消融范围、性别密切相关。

关键词: 肝癌, 微波治疗术, 肾功能不全, 危险因素

Abstract:

Objective To explore the influence of renal insufficiency with microwave therapy in the treatment of liver cancer.Methods A retrospective clinical analysis with 80 patients who underwent microwave therapy of liver cancer,was performed from June 2012 to March 2014 in the department of hepatobiliary and pancreatic surgery,the Affiliated Tumor Hospital of Harbin Medical University.According to perioperative presence of renal insufficiency,we divided the patients into renal dysfunction group(A)(n=44)and normal renal function group(B)(n=36);Preoperative ALT,TBIL,BUN,intraoperative hypotension,intraoperative urinary volume,age,the distance between the tumor and the main vessels in the liver,postoperative microwave ablation time the differences of the risk factors,such as microwave ablation range and sex of the two groups were compared during microwave therapy.Results There was no statistical significant difference between the two groups on intraoperative urinary volume(P＞0.05);The preoperative ALT,TBIL,BUN,intraoperative hypotension,age,microwave ablation time,the distance between the tumor and the main vessels in the liver,scular microwave ablation range,sex of two groups showed statistical differences(P＜0.05).BUN with preoperative ALT,TBIL,preoperative BUN,intraoperative hypotension,age,the distance between the tumor and the main vessels in the liver,time of microwave ablation,microwave ablation range,sex influence factors were positively correlated(r=0.63,0.60,0.58,0.49,0.45,0.40,0.35,0.46,0.52,P＜0.05).Strength and influencing factors of BUN are the distance between the tumor and the main vessels in the liver,microwave ablation range,intraoperative hypotension,preoperative ALT,sex,preoperative TBIL,microwave ablation time,age,preoperative BUN(β=0.52,0.42,0.37,0.31,0.29,0.25,0.20,0.18,0.16,P＜0.05).Conclusion Microwave therapy leads to renal insufficiency in the treatment of liver cancer performs many aspects,including preoperative ALT,TBIL,preoperative preoperative BUN,intraoperative hypotension,age,the distance between the tumor and the main vessels in the liver,time of microwave ablation,microwave ablation range,sex,which is closely related to the factors affecting the risk of kidney.

Key words: Liver cancer, Microwave healing, Renal insufficiency, Risk factors

中图分类号:

R735.7

刘春勋, 孙建民, 张玉宝, 赵红伟. 肝癌微波治疗术对患者肾功能影响因素的分析[J]. 实用肿瘤学杂志, 2015, 29(3): 212-215.

LIU Chunxun,SUN Jianmin,ZHANG Yubao,ZHAO Hongwei. Analysis on the influence factors of renal insufficiency in patients with hepatocellular carcinoma during microwave therapy[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 212-215.

参考文献

1 Shiina S,Teratani T,Obi S.A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma[J].Gastroenterology,2011,12(4):117-119.
2 张丽英,李开艳,张婷婷,等.原发性肝癌直接微波消融的疗效分析[N].华中科技大学学报(医学版),2013,42(6):707-711.
3 Livraghi T,Meloni F,Solbiati L,et al.Complications of microwave ablation for liver tumors:results of a multicenter study[J].Cardiovasc Intervent Radiol,2012,35(4):868-874.
4 中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志,2001,9(6):324-325.
5 刘静,卢实春,王孟龙,等.影响肝移植术后早期急性肾功能不全相关危险因素分析[J].肝胆外科杂志,2011,19(3):187-189.
6 Wiggermann P,Zuber-Jerger I,Zausig Y,et al.Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation:Preliminary results[J].Clin Hemorheol Microcirc,2011,49(1-4):43-54.
7 郭大伟,魏云涛,侯学忠,等.肝癌微波治疗术中出现血红蛋白尿的影响因素[J].现代肿瘤医学,2009,17(3):504-507.
8 Jayaraman S,Khakhar A,Yang H,et al.The association between central venous pressure,pneumoperitoneum,and venous carbon dioxide embolism in laparoscopic hepatectomy[J].Surg Endosc,2009,23(10):2369-2373.
9 Parkin DM,Bray F,Ferlay J,et al.Global Cancer Statistics,2010[J].CA:A Cancer Journal for Clinicians,2010,15(8):117-119.
10 吴丽娜,迟峰,吴荣.化疗及联合治疗对广泛期小细胞肺癌的疗效对比研究[J]实用肿瘤学杂志,2008,22(6):509-511.
11 郝秀丽,吕晓君.以肺外症状为首发的原发性肺癌166例临床分析[J].实用肿瘤学杂志,2008,22(6):526-527.
12 Martin RC,Scoggins CR,McMasters KM.Safety and efficacy of microwave ablation of hepatic tumors:A prospective review of a 5-year experience[J].Ann Surg Oncol,2010,17(1):171-173.

[1]	孙力超,杨婧,孙立新,张媛,杨治华,冉宇靓. 采用肝癌球体细胞筛选鉴定识别肝癌干细胞的单抗[J]. 实用肿瘤学杂志, 2019, 33(3): 193-199.
[2]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[3]	徐兵, 黄素钦, 吴林岚, 魏建威, 杨晓梅, 赵芝萍, 陈怡, 蒋晓织. 异体淋巴细胞和自体淋巴细胞序贯局部注射对小鼠肝癌移植瘤的治疗作用[J]. 实用肿瘤学杂志, 2018, 32(6): 493-497.
[4]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[5]	贺伟, 母齐鸣, 王刚, 万波, 廖波, 杨娟. TACC3和p53蛋白在原发性肝癌组织中的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 420-425.
[6]	万静萱, 李红红, 周湘乡, 马琳. Ⅳ期肺癌合并肺血栓栓塞的危险因素分析[J]. 实用肿瘤学杂志, 2018, 32(3): 214-244.
[7]	石小康(综述), 丁佑铭(审校). 螺杆菌属与原发性肝癌关系的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 271-274.
[8]	文娟娟, 瞿兵, 刘超. 肝癌组织中抗凝血酶Ⅲ基因表达的临床意义[J]. 实用肿瘤学杂志, 2018, 32(2): 117-121.
[9]	王睿,余陈欢,方杰. miR-409-5p对肝癌细胞系HepG2增殖及迁移的影响[J]. 实用肿瘤学杂志, 2017, 31(4): 305-309.
[10]	倪成香,闻静,初幸之,许禅,翟建军. 39例原发性输卵管癌临床病理分析[J]. 实用肿瘤学杂志, 2017, 31(4): 335-341.
[11]	周春芳，赵珊珊，孙泽群，吴军，查火龙，袁雅红. 酸性环境诱导肝癌HepG2细胞EMT[J]. 实用肿瘤学杂志, 2017, 31(3): 199-204.
[12]	张丽霞，潘双花，何英平. 原发性肝癌患者心电图与转氨酶和电解质的相关性研究[J]. 实用肿瘤学杂志, 2016, 30(6): 523-526.
[13]	杨晓文, 于爱清, 杨毅. Nanog调控细胞周期相关蛋白影响HepG2细胞增殖能力[J]. 实用肿瘤学杂志, 2016, 30(5): 425-429.
[14]	赵相轩, 温锋, 毛晓楠综述, 卢再鸣审校. 细胞凋亡在原发性肝癌治疗中的作用研究进展[J]. 实用肿瘤学杂志, 2016, 30(5): 448-452.
[15]	廖先珍, 颜仕鹏, 石菊芳, 石朝晖, 邹艳花, 肖海帆, 许可葵, 朱松林. 城市女性乳腺癌高危评估及筛查结果分析[J]. 实用肿瘤学杂志, 2016, 30(3): 245-248.